lumiracoxib: Clinical Trials

17 trials of lumiracoxib, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

16 completed, 1 terminated. 9 Phase 3, 7 Phase 4, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	9	Completed 9
Phase 4	7	Completed 7
Phase 2	1	Terminated 1

Follow lumiracoxib: new trials by email Literature Review of lumiracoxib trials Research Report on lumiracoxib

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia Lumiracoxib, Diclofenac - Kidney Failure, Chronic, Arthralgia	Phase 2	Terminated	Hospital Central Sur de Pemex	28	2012-01-01	2013-02-13
Effects of Lumiracoxib and Ibuprofen on Blood Pressure and Urinary Eicosanoid Excretion in Osteoarthritis Patients With Controlled Hypertension Lumiracoxib - Osteoarthritis With Controlled Hypertension	Phase 4	Completed	Novartis	78	2006-11-01	2007-11-29
Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery Lumiracoxib - Pain	Phase 4	Completed	Novartis	110	2006-08-01	2007-12-13
Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel Lumiracoxib - Healthy Volunteers	Phase 4	Completed	Novartis	150	2006-05-01	2007-12-13
Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib Lumiracoxib - Pain	Phase 4	Completed	Novartis Pharmaceuticals	364	2006-02-01	2017-02-23
Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension lumiracoxib - Osteoarthritis, Controlled Hypertension	Phase 4	Completed	Novartis Pharmaceuticals	1020	2005-11-01	2017-02-07
Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout Lumiracoxib - Acute Gouty Arthritis	Phase 4	Completed	Novartis	234	2005-06-01	2006-11-30
Safety and Efficacy of Lumiracoxib Versus Naproxen in Acute Musculoskeletal Pain Lumiracoxib - Musculoskeletal Pain	Phase 4	Completed	Novartis	419	2004-11-01	2006-10-13
Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis Lumiracoxib (drug) - Osteoarthritis, Hip	Phase 3	Completed	Novartis	1200	2004-11-01	2012-05-21
6 Week Open-label Trial With Lumiracoxib 200mg o.d. in Primary Knee Osteoarthritis or Rheumatoid Arthritis Lumiracoxib - Osteoarthritis, Rheumatoid Arthritis	Phase 3	Completed	Novartis	135	2004-11-01	2012-05-21
52 Week, International, Multi-center, Randomized, Double-blind, Double-dummy, Parallel-group Clinical Trial to Compare Retention on Treatment, Safety, Tolerability & Efficacy of Lumiracoxib 100 mg od, Lumiracoxib 100 mg Bid & Celecoxib 200 mg od in Pts With Primary OA of Hip, Knee, Hand or Spine Lumiracoxib - Osteoarthritis	Phase 3	Completed	Novartis	3036	2004-09-01	2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA) Lumiracoxib - Osteoarthritis	Phase 3	Completed	Novartis	833	2004-01-01	2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA) lumiracoxib - Osteoarthritis	Phase 3	Completed	Novartis	1312	2003-12-01	2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA) Lumiracoxib - Knee Osteoarthritis	Phase 3	Completed	Novartis	1684	2003-09-01	2012-05-21
Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA). Lumiracoxib - Osteoarthritis, Knee	Phase 3	Completed	Novartis	1464	2003-09-01	2012-05-21
Safety of Lumiracoxib in Patients With Osteoarthritis lumiracoxib, rofecoxib - Osteoarthritis	Phase 3	Completed	Novartis	309	2000-12-01	2008-03-18
Efficacy and Safety of Lumiracoxib Lumiracoxib - Osteoarthritis	Phase 3	Completed	Novartis	330	2000-11-01	2012-05-21

Conditions studied

Sponsors

Countries

Top investigators

Results publications